XML 30 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Net Income Per Share Data
6 Months Ended
Mar. 31, 2017
Earnings Per Share [Abstract]  
Net Income Per Share Data

12. Net Income Per Share Data

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of common and common equivalent shares outstanding during the period. The Company’s potentially dilutive common shares are those that result from dilutive common stock options, non-vested stock relating to restricted stock awards, restricted stock units, deferred stock units and performance shares.

The following table sets forth the denominator for the computation of basic and diluted net income per share (in thousands):

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Net income available to common shareholders

 

$

506

 

 

$

821

 

 

$

2,806

 

 

$

3,474

 

Basic weighted average shares outstanding

 

 

13,220

 

 

 

12,969

 

 

 

13,207

 

 

 

12,956

 

Dilutive effect of outstanding stock options, non-vested

   restricted stock, restricted stock units, deferred stock

   units and performance shares

 

 

208

 

 

 

221

 

 

 

208

 

 

 

231

 

Diluted weighted average shares outstanding

 

 

13,428

 

 

 

13,190

 

 

 

13,415

 

 

 

13,187

 

 

The calculation of weighted average diluted shares outstanding excludes outstanding stock options associated with the right to purchase 0.5 million and 0.9 million shares of common stock for the three months ended March 31, 2017 and 2016, respectively, and $0.3 million and 0.8 million for the six months ended March 31, 2017 and 2016, respectively as their inclusion would have had an antidilutive effect on diluted net income per share.                                            

The Company’s Board of Directors has authorized the repurchase of up to $30.0 million of the Company’s outstanding common stock. This authorization does not have an expiration date.